Krystal Biotech, Inc. (NASDAQ:KRYS) Stock Position Decreased by BNP Paribas Financial Markets
BNP Paribas Financial Markets cut its position in shares of Krystal Biotech, Inc. (NASDAQ:KRYS – Free Report) by 25.3% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 7,789 shares of the company’s stock after selling 2,644 shares during the period. BNP […]
BNP Paribas Financial Markets cut its position in shares of Krystal Biotech, Inc. (NASDAQ:KRYS – Free Report) by 25.3% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 7,789 shares of the company’s stock after selling 2,644 shares during the period. BNP […]
